Serum trypsinogen-2 and trypsin-2-alpha(1)-antitrypsin complex in malignant and benign digestive-tract diseases. Preferential elevation in patients with cholangiocarcinomas.

Source:http://linkedlifedata.com/resource/pubmed/id/8621252

Int. J. Cancer 1996 May 3 66 3 326-31

Download in:

View as

General Info

PMID
8621252